GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
Sanjay KHANDEKAR,Patrick MAYES,Joanna OPALINSKA
申请号：
US16646875
公开号：
US20200254093A1
申请日:
2018.09.12
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and an immunomodulatory drug (e.g. pomalidomide or lenalidomide). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone).
